Literature DB >> 26976768

The protective effect of total phenolics from Oenanthe Javanica on acute liver failure induced by D-galactosamine.

Guo Ai1, Zheng-Ming Huang2, Qing-Chuan Liu3, Yan-Quan Han4, Xi Chen5.   

Abstract

ETHNOPHARMACOLOGY RELEVANCE: Water dropwort [Oenanthe javanica (O. javanica)] is an aquatic perennial herb cultivated in East Asian countries. It has been popularly used in traditional Chinese medicine which is beneficial for the treatment of many diseases, including jaundice and various types of chronic and acute hepatitis. In the present study, we investigated the hepatoprotective effect of total phenolics from O. javanica (TPOJ) against D-galactosamine (D-GalN) induced liver injury in mice.
MATERIAL AND METHODS: The hepatoprotective activity of TPOJ (125, 250 and 500mg/kg) was investigated on D-GalN (800mg/kg)-induced liver damages in mice. Blood and liver were collected for biochemical and microscopic analysis. RT-PCR was used to determine the changes in hepatic nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) expression. Protein levels of iNOS, COX-2, superoxide dismutase (SOD), glutathione peroxidase (GPx), and catalase (CAT) were determined by western blotting.
RESULTS: In the animal studies, TPOJ could improve the survival of acute liver failure model significantly and prevente the D-GalN-induced elevation of the serum enzymatic markers and nonenzymatic markers levels significantly. Meanwhile, TPOJ-treatment decreased the malondialdehyde (MDA) level and elevated the content of glutathione (GSH) in the liver as compared to those in the D-GalN group. Hepatic activities and protein expressions of antioxidative enzymes, including SOD, GPx, and CAT were enhanced dose dependently with TPOJ. At the same time, application of TPOJ effectively suppressed the D-GalN-induced proinflammatory mRNA and protein expression of iNOS and COX-2. Subsequently, the serum levels of proinflammatory mediators, nitric oxide (NO) and prostaglandin E2 (PGE2) were reduced. Additionally, histological analyses also showed that TPOJ reduced the extent of liver lesions induced by D-GalN.
CONCLUSION: Our investigation demonstrated the hepatoprotective activity of TPOJ and revealed that TPOJ attributed its significance in the traditional use for treating liver diseases.
Copyright © 2016. Published by Elsevier Ireland Ltd.

Entities:  

Keywords:  D-Galactosamine; Hepatoprotective effect; Oenanthe Javanica; Total phenolics

Mesh:

Substances:

Year:  2016        PMID: 26976768     DOI: 10.1016/j.jep.2016.03.024

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  5 in total

1.  A Novel Antiviral Protein Derived from Oenanthe javanica: Type I Interferon-Dependent Antiviral Signaling and Its Pharmacological Potential.

Authors:  Bo-Ram Jo; Hyun-Soo Kim; Jeong-Won Ahn; Eui-Young Jeoung; Su-Kil Jang; Yeong-Min Yoo; Seong-Soo Joo
Journal:  Biomolecules       Date:  2022-06-16

2.  Hepatoprotective Effects of Nicotiflorin from Nymphaea candida against Concanavalin A-Induced and D-Galactosamine-Induced Liver Injury in Mice.

Authors:  Jun Zhao; Shilei Zhang; Shuping You; Tao Liu; Fang Xu; Tengfei Ji; Zhengyi Gu
Journal:  Int J Mol Sci       Date:  2017-03-08       Impact factor: 5.923

3.  The hepatoprotective activities of Kalimeris indica ethanol extract against liver injury in vivo.

Authors:  Guo-Kai Wang; Nan Zhang; Yi Wang; Jin-Song Liu; Gang Wang; Zhong-Yu Zhou; Chi-Cheng Lu; Jai-Sing Yang
Journal:  Food Sci Nutr       Date:  2019-10-18       Impact factor: 2.863

4.  Hepatoprotective Effects of Kaempferol-3-O-α-l-Arabinopyranosyl-7-O-α-l-Rhamnopyranoside on d-Galactosamine and Lipopolysaccharide Caused Hepatic Failure in Mice.

Authors:  Lin Dong; Lei Yin; Hongfeng Quan; Yuankui Chu; Jincai Lu
Journal:  Molecules       Date:  2017-10-18       Impact factor: 4.411

Review 5.  A Review of Oenanthe javanica (Blume) DC. as Traditional Medicinal Plant and Its Therapeutic Potential.

Authors:  Chuan-Li Lu; Xiu-Fen Li
Journal:  Evid Based Complement Alternat Med       Date:  2019-04-01       Impact factor: 2.629

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.